#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The application of the Second Law of Thermodynamics to living beings has its initial applications from the middle of the past century with two symbolical works proposed by Schrödinger and Prigogine and Wiane .
2-1	16-19	The	abstract[2]	new[2]	ana	2-13[0_2]
2-2	20-31	application	abstract[2]	new[2]	_	_
2-3	32-34	of	abstract[2]	new[2]	_	_
2-4	35-38	the	abstract[2]|person[3]	new[2]|new[3]	coref	3-10[17_3]
2-5	39-45	Second	abstract[2]|person[3]	new[2]|new[3]	_	_
2-6	46-49	Law	abstract[2]|person[3]	new[2]|new[3]	_	_
2-7	50-52	of	abstract[2]|person[3]	new[2]|new[3]	_	_
2-8	53-67	Thermodynamics	abstract[2]|person[3]|substance	new[2]|new[3]|new	coref	3-14
2-9	68-70	to	_	_	_	_
2-10	71-77	living	_	_	_	_
2-11	78-84	beings	person	new	coref	4-21[26_0]
2-12	85-88	has	_	_	_	_
2-13	89-92	its	abstract|abstract[7]	giv|new[7]	coref|coref	4-8[23_7]|4-8[23_7]
2-14	93-100	initial	abstract[7]	new[7]	_	_
2-15	101-113	applications	abstract[7]	new[7]	_	_
2-16	114-118	from	abstract[7]	new[7]	_	_
2-17	119-122	the	abstract[7]|time[8]	new[7]|new[8]	_	_
2-18	123-129	middle	abstract[7]|time[8]	new[7]|new[8]	_	_
2-19	130-132	of	abstract[7]|time[8]	new[7]|new[8]	_	_
2-20	133-136	the	abstract[7]|time[8]|time[9]	new[7]|new[8]|new[9]	_	_
2-21	137-141	past	abstract[7]|time[8]|time[9]	new[7]|new[8]|new[9]	_	_
2-22	142-149	century	abstract[7]|time[8]|time[9]	new[7]|new[8]|new[9]	_	_
2-23	150-154	with	_	_	_	_
2-24	155-158	two	abstract[10]	new[10]	coref	3-1[14_10]
2-25	159-169	symbolical	abstract[10]	new[10]	_	_
2-26	170-175	works	abstract[10]	new[10]	_	_
2-27	176-184	proposed	_	_	_	_
2-28	185-187	by	_	_	_	_
2-29	188-199	Schrödinger	person	new	_	_
2-30	200-203	and	_	_	_	_
2-31	204-213	Prigogine	person	new	_	_
2-32	214-217	and	_	_	_	_
2-33	218-223	Wiane	person	new	_	_
2-34	224-225	.	_	_	_	_

#Text=These works open a new field of application of the Second Law of Thermodynamics , nowadays usually applied by means of the Exergy Analysis .
3-1	226-231	These	abstract[14]	giv[14]	_	_
3-2	232-237	works	abstract[14]	giv[14]	_	_
3-3	238-242	open	_	_	_	_
3-4	243-244	a	abstract[15]	new[15]	coref	4-6[22_15]
3-5	245-248	new	abstract[15]	new[15]	_	_
3-6	249-254	field	abstract[15]	new[15]	_	_
3-7	255-257	of	abstract[15]	new[15]	_	_
3-8	258-269	application	abstract[15]|abstract[16]	new[15]|new[16]	coref	5-39[45_16]
3-9	270-272	of	abstract[15]|abstract[16]	new[15]|new[16]	_	_
3-10	273-276	the	abstract[15]|abstract[16]|person[17]	new[15]|new[16]|giv[17]	coref	4-13[24_17]
3-11	277-283	Second	abstract[15]|abstract[16]|person[17]	new[15]|new[16]|giv[17]	_	_
3-12	284-287	Law	abstract[15]|abstract[16]|person[17]	new[15]|new[16]|giv[17]	_	_
3-13	288-290	of	abstract[15]|abstract[16]|person[17]	new[15]|new[16]|giv[17]	_	_
3-14	291-305	Thermodynamics	abstract[15]|abstract[16]|person[17]|abstract	new[15]|new[16]|giv[17]|giv	coref	6-27
3-15	306-307	,	_	_	_	_
3-16	308-316	nowadays	_	_	_	_
3-17	317-324	usually	_	_	_	_
3-18	325-332	applied	_	_	_	_
3-19	333-335	by	_	_	_	_
3-20	336-341	means	_	_	_	_
3-21	342-344	of	_	_	_	_
3-22	345-348	the	abstract[20]	new[20]	_	_
3-23	349-355	Exergy	abstract|abstract[20]	new|new[20]	_	_
3-24	356-364	Analysis	abstract[20]	new[20]	_	_
3-25	365-366	.	_	_	_	_

#Text=As proposed by Oliveira , one of the most interesting applications of the Second Law is understanding the functioning of living beings and use the physical property entropy generation ( or destroyed exergy ) as an indicator or diagnosis of pathology .
4-1	367-369	As	_	_	_	_
4-2	370-378	proposed	_	_	_	_
4-3	379-381	by	_	_	_	_
4-4	382-390	Oliveira	person	new	_	_
4-5	391-392	,	_	_	_	_
4-6	393-396	one	abstract[22]	giv[22]	coref	6-10[57_22]
4-7	397-399	of	abstract[22]	giv[22]	_	_
4-8	400-403	the	abstract[22]|abstract[23]	giv[22]|giv[23]	coref	6-20[59_23]
4-9	404-408	most	abstract[22]|abstract[23]	giv[22]|giv[23]	_	_
4-10	409-420	interesting	abstract[22]|abstract[23]	giv[22]|giv[23]	_	_
4-11	421-433	applications	abstract[22]|abstract[23]	giv[22]|giv[23]	_	_
4-12	434-436	of	abstract[22]|abstract[23]	giv[22]|giv[23]	_	_
4-13	437-440	the	abstract[22]|abstract[23]|person[24]	giv[22]|giv[23]|giv[24]	_	_
4-14	441-447	Second	abstract[22]|abstract[23]|person[24]	giv[22]|giv[23]|giv[24]	_	_
4-15	448-451	Law	abstract[22]|abstract[23]|person[24]	giv[22]|giv[23]|giv[24]	_	_
4-16	452-454	is	_	_	_	_
4-17	455-468	understanding	_	_	_	_
4-18	469-472	the	abstract[25]	new[25]	_	_
4-19	473-484	functioning	abstract[25]	new[25]	_	_
4-20	485-487	of	abstract[25]	new[25]	_	_
4-21	488-494	living	abstract[25]|person[26]	new[25]|giv[26]	coref	6-30[63_26]
4-22	495-501	beings	abstract[25]|person[26]	new[25]|giv[26]	_	_
4-23	502-505	and	_	_	_	_
4-24	506-509	use	_	_	_	_
4-25	510-513	the	abstract[29]	new[29]	appos	4-32[30_29]
4-26	514-522	physical	abstract[29]	new[29]	_	_
4-27	523-531	property	abstract|abstract[29]	new|new[29]	_	_
4-28	532-539	entropy	abstract|abstract[29]	new|new[29]	_	_
4-29	540-550	generation	abstract[29]	new[29]	_	_
4-30	551-552	(	_	_	_	_
4-31	553-555	or	_	_	_	_
4-32	556-565	destroyed	abstract[30]	giv[30]	coref	5-57[52_30]
4-33	566-572	exergy	abstract[30]	giv[30]	_	_
4-34	573-574	)	_	_	_	_
4-35	575-577	as	_	_	_	_
4-36	578-580	an	_	_	_	_
4-37	581-590	indicator	_	_	_	_
4-38	591-593	or	_	_	_	_
4-39	594-603	diagnosis	_	_	_	_
4-40	604-606	of	_	_	_	_
4-41	607-616	pathology	abstract	new	_	_
4-42	617-618	.	_	_	_	_

#Text=This assessment tool was applied to a cancerous cell , neuron under hypoxia , human lungs , human heart , athletes under different training level , hypothermia as a therapy , orientated healing of burned patients and , the most common application , the analysis of thermal comfort conditions ( comparison of the comfort indexes with destroyed exergy and exergy efficiency ) systematized in .
5-1	619-623	This	abstract[33]	new[33]	_	_
5-2	624-634	assessment	abstract|abstract[33]	new|new[33]	_	_
5-3	635-639	tool	abstract[33]	new[33]	_	_
5-4	640-643	was	_	_	_	_
5-5	644-651	applied	_	_	_	_
5-6	652-654	to	_	_	_	_
5-7	655-656	a	object[34]	new[34]	_	_
5-8	657-666	cancerous	object[34]	new[34]	_	_
5-9	667-671	cell	object[34]	new[34]	_	_
5-10	672-673	,	_	_	_	_
5-11	674-680	neuron	abstract[35]	new[35]	_	_
5-12	681-686	under	abstract[35]	new[35]	_	_
5-13	687-694	hypoxia	abstract[35]|abstract	new[35]|new	coref	13-40
5-14	695-696	,	abstract[35]	new[35]	_	_
5-15	697-702	human	abstract[35]|object[37]	new[35]|new[37]	_	_
5-16	703-708	lungs	abstract[35]|object[37]	new[35]|new[37]	_	_
5-17	709-710	,	abstract[35]	new[35]	_	_
5-18	711-716	human	abstract[35]|object[38]	new[35]|new[38]	_	_
5-19	717-722	heart	abstract[35]|object[38]	new[35]|new[38]	_	_
5-20	723-724	,	abstract[35]	new[35]	_	_
5-21	725-733	athletes	abstract[35]|person[39]	new[35]|new[39]	_	_
5-22	734-739	under	abstract[35]|person[39]	new[35]|new[39]	_	_
5-23	740-749	different	abstract[35]|person[39]|abstract[41]	new[35]|new[39]|new[41]	_	_
5-24	750-758	training	abstract[35]|person[39]|abstract|abstract[41]	new[35]|new[39]|new|new[41]	_	_
5-25	759-764	level	abstract[35]|person[39]|abstract[41]	new[35]|new[39]|new[41]	_	_
5-26	765-766	,	abstract[35]|person[39]	new[35]|new[39]	_	_
5-27	767-778	hypothermia	abstract[35]|person[39]|abstract[42]	new[35]|new[39]|new[42]	_	_
5-28	779-781	as	abstract[35]|person[39]|abstract[42]	new[35]|new[39]|new[42]	_	_
5-29	782-783	a	abstract[35]|person[39]|abstract[42]	new[35]|new[39]|new[42]	_	_
5-30	784-791	therapy	abstract[35]|person[39]|abstract[42]	new[35]|new[39]|new[42]	_	_
5-31	792-793	,	_	_	_	_
5-32	794-804	orientated	_	_	_	_
5-33	805-812	healing	abstract[43]	new[43]	_	_
5-34	813-815	of	abstract[43]	new[43]	_	_
5-35	816-822	burned	abstract[43]|person[44]	new[43]|new[44]	_	_
5-36	823-831	patients	abstract[43]|person[44]	new[43]|new[44]	_	_
5-37	832-835	and	abstract[43]|person[44]	new[43]|new[44]	_	_
5-38	836-837	,	abstract[43]|person[44]	new[43]|new[44]	_	_
5-39	838-841	the	abstract[43]|person[44]|abstract[45]	new[43]|new[44]|giv[45]	appos	5-44[46_45]
5-40	842-846	most	abstract[43]|person[44]|abstract[45]	new[43]|new[44]|giv[45]	_	_
5-41	847-853	common	abstract[43]|person[44]|abstract[45]	new[43]|new[44]|giv[45]	_	_
5-42	854-865	application	abstract[43]|person[44]|abstract[45]	new[43]|new[44]|giv[45]	_	_
5-43	866-867	,	_	_	_	_
5-44	868-871	the	abstract[46]	giv[46]	_	_
5-45	872-880	analysis	abstract[46]	giv[46]	_	_
5-46	881-883	of	abstract[46]	giv[46]	_	_
5-47	884-891	thermal	abstract[46]|abstract[48]	giv[46]|new[48]	coref	25-34[0_48]
5-48	892-899	comfort	abstract[46]|abstract|abstract[48]	giv[46]|new|new[48]	coref	5-54
5-49	900-910	conditions	abstract[46]|abstract[48]	giv[46]|new[48]	_	_
5-50	911-912	(	_	_	_	_
5-51	913-923	comparison	abstract[49]	new[49]	_	_
5-52	924-926	of	abstract[49]	new[49]	_	_
5-53	927-930	the	abstract[49]|abstract[51]	new[49]|new[51]	_	_
5-54	931-938	comfort	abstract[49]|abstract|abstract[51]	new[49]|giv|new[51]	_	_
5-55	939-946	indexes	abstract[49]|abstract[51]	new[49]|new[51]	_	_
5-56	947-951	with	abstract[49]|abstract[51]	new[49]|new[51]	_	_
5-57	952-961	destroyed	abstract[49]|abstract[51]|abstract[52]	new[49]|new[51]|giv[52]	coref	5-60[0_52]
5-58	962-968	exergy	abstract[49]|abstract[51]|abstract[52]	new[49]|new[51]|giv[52]	_	_
5-59	969-972	and	abstract[49]|abstract[51]	new[49]|new[51]	_	_
5-60	973-979	exergy	abstract[49]|abstract[51]|abstract|abstract[54]	new[49]|new[51]|giv|new[54]	coref|coref	25-6|25-6
5-61	980-990	efficiency	abstract[49]|abstract[51]|abstract[54]	new[49]|new[51]|new[54]	_	_
5-62	991-992	)	_	_	_	_
5-63	993-1005	systematized	_	_	_	_
5-64	1006-1008	in	_	_	_	_
5-65	1009-1010	.	_	_	_	_

#Text=Furthermore , Ozilgen carried out an extensive review of this area , pointing out that this field has promising applications in several areas of interaction of Thermodynamics with living beings ’ behavior .
6-1	1011-1022	Furthermore	_	_	_	_
6-2	1023-1024	,	_	_	_	_
6-3	1025-1032	Ozilgen	person	new	_	_
6-4	1033-1040	carried	_	_	_	_
6-5	1041-1044	out	_	_	_	_
6-6	1045-1047	an	abstract[56]	new[56]	_	_
6-7	1048-1057	extensive	abstract[56]	new[56]	_	_
6-8	1058-1064	review	abstract[56]	new[56]	_	_
6-9	1065-1067	of	abstract[56]	new[56]	_	_
6-10	1068-1072	this	abstract[56]|abstract[57]	new[56]|giv[57]	coref	6-16[58_57]
6-11	1073-1077	area	abstract[56]|abstract[57]	new[56]|giv[57]	_	_
6-12	1078-1079	,	_	_	_	_
6-13	1080-1088	pointing	_	_	_	_
6-14	1089-1092	out	_	_	_	_
6-15	1093-1097	that	_	_	_	_
6-16	1098-1102	this	abstract[58]	giv[58]	_	_
6-17	1103-1108	field	abstract[58]	giv[58]	_	_
6-18	1109-1112	has	_	_	_	_
6-19	1113-1122	promising	_	_	_	_
6-20	1123-1135	applications	abstract[59]	giv[59]	_	_
6-21	1136-1138	in	abstract[59]	giv[59]	_	_
6-22	1139-1146	several	abstract[59]|place[60]	giv[59]|new[60]	_	_
6-23	1147-1152	areas	abstract[59]|place[60]	giv[59]|new[60]	_	_
6-24	1153-1155	of	abstract[59]|place[60]	giv[59]|new[60]	_	_
6-25	1156-1167	interaction	abstract[59]|place[60]|abstract[61]	giv[59]|new[60]|new[61]	_	_
6-26	1168-1170	of	abstract[59]|place[60]|abstract[61]	giv[59]|new[60]|new[61]	_	_
6-27	1171-1185	Thermodynamics	abstract[59]|place[60]|abstract[61]|abstract	giv[59]|new[60]|new[61]|giv	_	_
6-28	1186-1190	with	_	_	_	_
6-29	1191-1197	living	_	_	_	_
6-30	1198-1204	beings	person[63]|abstract[64]	giv[63]|new[64]	ana|ana	7-10[0_64]|7-10[0_64]
6-31	1205-1206	’	person[63]|abstract[64]	giv[63]|new[64]	_	_
6-32	1207-1215	behavior	abstract[64]	new[64]	_	_
6-33	1216-1217	.	_	_	_	_

#Text=Regarding the pollutant carbon monoxide ( CO ) , it is considered to be a harmful gas since it bounds to hemoglobin , decreasing the blood capacity to deliver oxygen to tissues .
7-1	1218-1227	Regarding	_	_	_	_
7-2	1228-1231	the	substance[67]	new[67]	appos	7-7[0_67]
7-3	1232-1241	pollutant	abstract|substance[67]	new|new[67]	_	_
7-4	1242-1248	carbon	substance|substance[67]	new|new[67]	coref	9-17
7-5	1249-1257	monoxide	substance[67]	new[67]	_	_
7-6	1258-1259	(	_	_	_	_
7-7	1260-1262	CO	substance	giv	coref	9-18
7-8	1263-1264	)	_	_	_	_
7-9	1265-1266	,	_	_	_	_
7-10	1267-1269	it	abstract	giv	ana	7-19
7-11	1270-1272	is	_	_	_	_
7-12	1273-1283	considered	_	_	_	_
7-13	1284-1286	to	_	_	_	_
7-14	1287-1289	be	_	_	_	_
7-15	1290-1291	a	substance[70]	new[70]	coref	8-17[0_70]
7-16	1292-1299	harmful	substance[70]	new[70]	_	_
7-17	1300-1303	gas	substance[70]	new[70]	_	_
7-18	1304-1309	since	_	_	_	_
7-19	1310-1312	it	abstract	giv	coref	24-10[200_0]
7-20	1313-1319	bounds	_	_	_	_
7-21	1320-1322	to	_	_	_	_
7-22	1323-1333	hemoglobin	substance	new	coref	11-6
7-23	1334-1335	,	_	_	_	_
7-24	1336-1346	decreasing	_	_	_	_
7-25	1347-1350	the	abstract[74]	new[74]	_	_
7-26	1351-1356	blood	substance|abstract[74]	new|new[74]	coref	15-41[146_0]
7-27	1357-1365	capacity	abstract[74]	new[74]	_	_
7-28	1366-1368	to	_	_	_	_
7-29	1369-1376	deliver	_	_	_	_
7-30	1377-1383	oxygen	substance	new	coref	13-32[125_0]
7-31	1384-1386	to	_	_	_	_
7-32	1387-1394	tissues	object	new	coref	13-36[126_0]
7-33	1395-1396	.	_	_	_	_

#Text=Pregnant women can be poisoned by work-related sources like some industrial process ( hot furnaces , gas refineries ) , or household sources like defective water heaters , or even passing through a tunnel in an urban environment .
8-1	1397-1405	Pregnant	person[77]	new[77]	_	_
8-2	1406-1411	women	person[77]	new[77]	_	_
8-3	1412-1415	can	_	_	_	_
8-4	1416-1418	be	_	_	_	_
8-5	1419-1427	poisoned	_	_	_	_
8-6	1428-1430	by	_	_	_	_
8-7	1431-1443	work-related	abstract[78]	new[78]	coref	8-22[85_78]
8-8	1444-1451	sources	abstract[78]	new[78]	_	_
8-9	1452-1456	like	abstract[78]	new[78]	_	_
8-10	1457-1461	some	abstract[78]|abstract[79]	new[78]|new[79]	appos	8-14[81_79]
8-11	1462-1472	industrial	abstract[78]|abstract[79]	new[78]|new[79]	_	_
8-12	1473-1480	process	abstract[78]|abstract[79]	new[78]|new[79]	_	_
8-13	1481-1482	(	_	_	_	_
8-14	1483-1486	hot	object[80]|abstract[81]	new[80]|giv[81]	_	_
8-15	1487-1495	furnaces	object[80]|abstract[81]	new[80]|giv[81]	_	_
8-16	1496-1497	,	abstract[81]	giv[81]	_	_
8-17	1498-1501	gas	abstract[81]|substance|substance[83]	giv[81]|giv|new[83]	coref|coref	13-2|13-2
8-18	1502-1512	refineries	abstract[81]|substance[83]	giv[81]|new[83]	_	_
8-19	1513-1514	)	_	_	_	_
8-20	1515-1516	,	_	_	_	_
8-21	1517-1519	or	_	_	_	_
8-22	1520-1529	household	place|abstract[85]	new|giv[85]	_	_
8-23	1530-1537	sources	abstract[85]	giv[85]	_	_
8-24	1538-1542	like	abstract[85]	giv[85]	_	_
8-25	1543-1552	defective	abstract[85]|abstract[87]	giv[85]|new[87]	_	_
8-26	1553-1558	water	abstract[85]|substance|abstract[87]	giv[85]|new|new[87]	_	_
8-27	1559-1566	heaters	abstract[85]|abstract[87]	giv[85]|new[87]	_	_
8-28	1567-1568	,	_	_	_	_
8-29	1569-1571	or	_	_	_	_
8-30	1572-1576	even	_	_	_	_
8-31	1577-1584	passing	_	_	_	_
8-32	1585-1592	through	_	_	_	_
8-33	1593-1594	a	object[88]	new[88]	coref	25-53[0_88]
8-34	1595-1601	tunnel	object[88]	new[88]	_	_
8-35	1602-1604	in	object[88]	new[88]	_	_
8-36	1605-1607	an	object[88]|place[89]	new[88]|new[89]	coref	25-52[221_89]
8-37	1608-1613	urban	object[88]|place[89]	new[88]|new[89]	_	_
8-38	1614-1625	environment	object[88]|place[89]	new[88]|new[89]	_	_
8-39	1626-1627	.	_	_	_	_

#Text=Smoking or being a passive smoker can also cause damage : a smoke-filled room has a carbon monoxide concentration as high as 100 ppm .
9-1	1628-1635	Smoking	_	_	_	_
9-2	1636-1638	or	_	_	_	_
9-3	1639-1644	being	_	_	_	_
9-4	1645-1646	a	person[90]	new[90]	_	_
9-5	1647-1654	passive	person[90]	new[90]	_	_
9-6	1655-1661	smoker	person[90]	new[90]	_	_
9-7	1662-1665	can	_	_	_	_
9-8	1666-1670	also	_	_	_	_
9-9	1671-1676	cause	_	_	_	_
9-10	1677-1683	damage	abstract	new	_	_
9-11	1684-1685	:	_	_	_	_
9-12	1686-1687	a	place[92]	new[92]	_	_
9-13	1688-1700	smoke-filled	place[92]	new[92]	_	_
9-14	1701-1705	room	place[92]	new[92]	_	_
9-15	1706-1709	has	_	_	_	_
9-16	1710-1711	a	abstract[95]	new[95]	coref	10-1[97_95]
9-17	1712-1718	carbon	substance|abstract[95]	giv|new[95]	coref	14-17
9-18	1719-1727	monoxide	substance|abstract[95]	giv|new[95]	coref	13-1[116_0]
9-19	1728-1741	concentration	abstract[95]	new[95]	_	_
9-20	1742-1744	as	_	_	_	_
9-21	1745-1749	high	_	_	_	_
9-22	1750-1752	as	_	_	_	_
9-23	1753-1756	100	quantity[96]	new[96]	_	_
9-24	1757-1760	ppm	quantity[96]	new[96]	_	_
9-25	1761-1762	.	_	_	_	_

#Text=This concentration is enough to cause a chronic poisoning , characterized by carboxyhemoglobin ( HbCO ) in the 5 – 25 % range .
10-1	1763-1767	This	abstract[97]	giv[97]	_	_
10-2	1768-1781	concentration	abstract[97]	giv[97]	_	_
10-3	1782-1784	is	_	_	_	_
10-4	1785-1791	enough	_	_	_	_
10-5	1792-1794	to	_	_	_	_
10-6	1795-1800	cause	_	_	_	_
10-7	1801-1802	a	abstract[98]	new[98]	coref	15-5[138_98]
10-8	1803-1810	chronic	abstract[98]	new[98]	_	_
10-9	1811-1820	poisoning	abstract[98]	new[98]	_	_
10-10	1821-1822	,	_	_	_	_
10-11	1823-1836	characterized	_	_	_	_
10-12	1837-1839	by	_	_	_	_
10-13	1840-1857	carboxyhemoglobin	plant	new	coref	14-13
10-14	1858-1859	(	_	_	_	_
10-15	1860-1864	HbCO	substance	new	_	_
10-16	1865-1866	)	_	_	_	_
10-17	1867-1869	in	_	_	_	_
10-18	1870-1873	the	quantity[103]	new[103]	_	_
10-19	1874-1875	5	quantity[103]	new[103]	_	_
10-20	1876-1877	–	quantity[103]	new[103]	_	_
10-21	1878-1880	25	quantity|quantity[103]	new|new[103]	_	_
10-22	1881-1882	%	quantity|quantity[103]	new|new[103]	_	_
10-23	1883-1888	range	quantity[103]	new[103]	_	_
10-24	1889-1890	.	_	_	_	_

#Text=The bind between O and hemoglobin ( ) forms oxyhemoglobin ( ) .
11-1	1891-1894	The	abstract[104]	new[104]	ana	13-7[0_104]
11-2	1895-1899	bind	abstract[104]	new[104]	_	_
11-3	1900-1907	between	abstract[104]	new[104]	_	_
11-4	1908-1909	O	abstract[104]|substance|substance[106]	new[104]|new|new[106]	coref|coref|coref|coref	19-19|21-3[183_106]|19-19|21-3[183_106]
11-5	1910-1913	and	abstract[104]|substance[106]	new[104]|new[106]	_	_
11-6	1914-1924	hemoglobin	abstract[104]|substance[106]|substance	new[104]|new[106]|giv	coref	12-1[109_0]
11-7	1925-1926	(	_	_	_	_
11-8	1927-1928	)	_	_	_	_
11-9	1929-1934	forms	_	_	_	_
11-10	1935-1948	oxyhemoglobin	substance	new	_	_
11-11	1949-1950	(	_	_	_	_
11-12	1951-1952	)	_	_	_	_
11-13	1953-1954	.	_	_	_	_

#Text=Each hemoglobin can carry four molecules of O. The easiness of the reaction increases when the first oxygenation occurs .
12-1	1955-1959	Each	substance[109]	giv[109]	coref	13-12[119_109]
12-2	1960-1970	hemoglobin	substance[109]	giv[109]	_	_
12-3	1971-1974	can	_	_	_	_
12-4	1975-1980	carry	_	_	_	_
12-5	1981-1985	four	substance[110]	new[110]	_	_
12-6	1986-1995	molecules	substance[110]	new[110]	_	_
12-7	1996-1998	of	substance[110]	new[110]	_	_
12-8	1999-2001	O.	substance[110]|person	new[110]|new	coref	13-20
12-9	2002-2005	The	substance[112]	new[112]	_	_
12-10	2006-2014	easiness	substance[112]	new[112]	_	_
12-11	2015-2017	of	substance[112]	new[112]	_	_
12-12	2018-2021	the	substance[112]|event[113]	new[112]|new[113]	coref	14-15[132_113]
12-13	2022-2030	reaction	substance[112]|event[113]	new[112]|new[113]	_	_
12-14	2031-2040	increases	abstract	new	coref|none	14-10[130_0]|12-14[0_130]
12-15	2041-2045	when	_	_	_	_
12-16	2046-2049	the	substance[114]	new[114]	_	_
12-17	2050-2055	first	substance[114]	new[114]	_	_
12-18	2056-2067	oxygenation	substance[114]	new[114]	_	_
12-19	2068-2074	occurs	_	_	_	_
12-20	2075-2076	.	_	_	_	_

#Text=The gas CO is toxic because it has an affinity with the hemoglobin 200 – 300 times greater than O. Hence , even relatively small concentrations of CO inspired can reduce the delivered oxygen to the tissues , causing hypoxia .
13-1	2077-2080	The	substance[116]	giv[116]	coref	13-28[0_116]
13-2	2081-2084	gas	substance|substance[116]	giv|giv[116]	_	_
13-3	2085-2087	CO	substance[116]	giv[116]	_	_
13-4	2088-2090	is	_	_	_	_
13-5	2091-2096	toxic	_	_	_	_
13-6	2097-2104	because	_	_	_	_
13-7	2105-2107	it	abstract	giv	_	_
13-8	2108-2111	has	_	_	_	_
13-9	2112-2114	an	abstract[118]	new[118]	_	_
13-10	2115-2123	affinity	abstract[118]	new[118]	_	_
13-11	2124-2128	with	abstract[118]	new[118]	_	_
13-12	2129-2132	the	abstract[118]|substance[119]	new[118]|giv[119]	coref	14-20[0_119]
13-13	2133-2143	hemoglobin	abstract[118]|substance[119]	new[118]|giv[119]	_	_
13-14	2144-2147	200	abstract[118]|substance[119]	new[118]|giv[119]	_	_
13-15	2148-2149	–	abstract[118]|substance[119]	new[118]|giv[119]	_	_
13-16	2150-2153	300	abstract[118]|substance[119]|quantity	new[118]|giv[119]|new	_	_
13-17	2154-2159	times	abstract[118]|substance[119]|time[121]	new[118]|giv[119]|new[121]	_	_
13-18	2160-2167	greater	abstract[118]|substance[119]|time[121]	new[118]|giv[119]|new[121]	_	_
13-19	2168-2172	than	_	_	_	_
13-20	2173-2175	O.	substance	giv	_	_
13-21	2176-2181	Hence	_	_	_	_
13-22	2182-2183	,	_	_	_	_
13-23	2184-2188	even	animal[123]	new[123]	_	_
13-24	2189-2199	relatively	animal[123]	new[123]	_	_
13-25	2200-2205	small	animal[123]	new[123]	_	_
13-26	2206-2220	concentrations	animal[123]	new[123]	_	_
13-27	2221-2223	of	animal[123]	new[123]	_	_
13-28	2224-2226	CO	animal[123]|substance	new[123]|giv	coref	14-6
13-29	2227-2235	inspired	_	_	_	_
13-30	2236-2239	can	_	_	_	_
13-31	2240-2246	reduce	_	_	_	_
13-32	2247-2250	the	substance[125]	giv[125]	coref	15-17[140_125]
13-33	2251-2260	delivered	substance[125]	giv[125]	_	_
13-34	2261-2267	oxygen	substance[125]	giv[125]	_	_
13-35	2268-2270	to	substance[125]	giv[125]	_	_
13-36	2271-2274	the	substance[125]|object[126]	giv[125]|giv[126]	_	_
13-37	2275-2282	tissues	substance[125]|object[126]	giv[125]|giv[126]	_	_
13-38	2283-2284	,	_	_	_	_
13-39	2285-2292	causing	_	_	_	_
13-40	2293-2300	hypoxia	event	giv	_	_
13-41	2301-2302	.	_	_	_	_

#Text=Therefore , the toxicity of CO is related to the increase of carboxyhemoglobin ( reaction of carbon monoxide with hemoglobin ) .
14-1	2303-2312	Therefore	_	_	_	_
14-2	2313-2314	,	_	_	_	_
14-3	2315-2318	the	abstract[128]	new[128]	_	_
14-4	2319-2327	toxicity	abstract[128]	new[128]	_	_
14-5	2328-2330	of	abstract[128]	new[128]	_	_
14-6	2331-2333	CO	abstract[128]|substance	new[128]|giv	coref	14-17[134_0]
14-7	2334-2336	is	_	_	_	_
14-8	2337-2344	related	_	_	_	_
14-9	2345-2347	to	_	_	_	_
14-10	2348-2351	the	abstract[130]	new[130]	_	_
14-11	2352-2360	increase	abstract[130]	new[130]	_	_
14-12	2361-2363	of	abstract[130]	new[130]	_	_
14-13	2364-2381	carboxyhemoglobin	abstract[130]|substance	new[130]|giv	_	_
14-14	2382-2383	(	_	_	_	_
14-15	2384-2392	reaction	event[132]	giv[132]	_	_
14-16	2393-2395	of	event[132]	giv[132]	_	_
14-17	2396-2402	carbon	event[132]|substance|substance[134]	giv[132]|giv|giv[134]	coref|coref	15-5[0_134]|15-5[0_134]
14-18	2403-2411	monoxide	event[132]|substance[134]	giv[132]|giv[134]	_	_
14-19	2412-2416	with	event[132]|substance[134]	giv[132]|giv[134]	_	_
14-20	2417-2427	hemoglobin	event[132]|substance[134]|substance	giv[132]|giv[134]|giv	_	_
14-21	2428-2429	)	_	_	_	_
14-22	2430-2431	.	_	_	_	_

#Text=The usual treatment of CO poisoning consists of reducing the inspired CO to zero and increasing the oxygen inspired , thus generating an increment in the gradients of these gases in the alveolar ventilation and increasing O partial pressure in the blood .
15-1	2432-2435	The	abstract[136]	new[136]	_	_
15-2	2436-2441	usual	abstract[136]	new[136]	_	_
15-3	2442-2451	treatment	abstract[136]	new[136]	_	_
15-4	2452-2454	of	abstract[136]	new[136]	_	_
15-5	2455-2457	CO	abstract[136]|substance|abstract[138]	new[136]|giv|giv[138]	coref|coref|coref|coref	15-10[139_0]|17-11[162_138]|15-10[139_0]|17-11[162_138]
15-6	2458-2467	poisoning	abstract[136]|abstract[138]	new[136]|giv[138]	_	_
15-7	2468-2476	consists	_	_	_	_
15-8	2477-2479	of	_	_	_	_
15-9	2480-2488	reducing	_	_	_	_
15-10	2489-2492	the	substance[139]	giv[139]	coref	21-5[0_139]
15-11	2493-2501	inspired	substance[139]	giv[139]	_	_
15-12	2502-2504	CO	substance[139]	giv[139]	_	_
15-13	2505-2507	to	_	_	_	_
15-14	2508-2512	zero	_	_	_	_
15-15	2513-2516	and	_	_	_	_
15-16	2517-2527	increasing	_	_	_	_
15-17	2528-2531	the	substance[140]	giv[140]	coref	20-4[0_140]
15-18	2532-2538	oxygen	substance[140]	giv[140]	_	_
15-19	2539-2547	inspired	_	_	_	_
15-20	2548-2549	,	_	_	_	_
15-21	2550-2554	thus	_	_	_	_
15-22	2555-2565	generating	_	_	_	_
15-23	2566-2568	an	abstract[141]	new[141]	_	_
15-24	2569-2578	increment	abstract[141]	new[141]	_	_
15-25	2579-2581	in	abstract[141]	new[141]	_	_
15-26	2582-2585	the	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-27	2586-2595	gradients	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-28	2596-2598	of	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-29	2599-2604	these	abstract[141]|abstract[142]|substance[143]	new[141]|new[142]|new[143]	coref	22-23[0_143]
15-30	2605-2610	gases	abstract[141]|abstract[142]|substance[143]	new[141]|new[142]|new[143]	_	_
15-31	2611-2613	in	abstract[141]|abstract[142]|substance[143]	new[141]|new[142]|new[143]	_	_
15-32	2614-2617	the	abstract[141]|abstract[142]|substance[143]|event[144]	new[141]|new[142]|new[143]|new[144]	_	_
15-33	2618-2626	alveolar	abstract[141]|abstract[142]|substance[143]|event[144]	new[141]|new[142]|new[143]|new[144]	_	_
15-34	2627-2638	ventilation	abstract[141]|abstract[142]|substance[143]|event[144]	new[141]|new[142]|new[143]|new[144]	_	_
15-35	2639-2642	and	_	_	_	_
15-36	2643-2653	increasing	_	_	_	_
15-37	2654-2655	O	abstract[145]	new[145]	_	_
15-38	2656-2663	partial	abstract[145]	new[145]	_	_
15-39	2664-2672	pressure	abstract[145]	new[145]	_	_
15-40	2673-2675	in	abstract[145]	new[145]	_	_
15-41	2676-2679	the	abstract[145]|substance[146]	new[145]|giv[146]	coref	22-26[194_146]
15-42	2680-2685	blood	abstract[145]|substance[146]	new[145]|giv[146]	_	_
15-43	2686-2687	.	_	_	_	_

#Text=The intoxication symptoms usually are headaches , sensations of weakness , dizziness , sleepiness , impaired physical performance , visual difficulties , palpitations , nausea , and vomiting .
16-1	2688-2691	The	abstract[148]	new[148]	_	_
16-2	2692-2704	intoxication	substance|abstract[148]	new|new[148]	_	_
16-3	2705-2713	symptoms	abstract[148]	new[148]	_	_
16-4	2714-2721	usually	_	_	_	_
16-5	2722-2725	are	_	_	_	_
16-6	2726-2735	headaches	abstract	new	_	_
16-7	2736-2737	,	_	_	_	_
16-8	2738-2748	sensations	abstract[150]	new[150]	_	_
16-9	2749-2751	of	abstract[150]	new[150]	_	_
16-10	2752-2760	weakness	abstract[150]|abstract	new[150]|new	_	_
16-11	2761-2762	,	abstract[150]	new[150]	_	_
16-12	2763-2772	dizziness	abstract[150]|abstract	new[150]|new	_	_
16-13	2773-2774	,	abstract[150]	new[150]	_	_
16-14	2775-2785	sleepiness	abstract[150]|abstract	new[150]|new	_	_
16-15	2786-2787	,	abstract[150]	new[150]	_	_
16-16	2788-2796	impaired	abstract[150]|abstract[154]	new[150]|new[154]	_	_
16-17	2797-2805	physical	abstract[150]|abstract[154]	new[150]|new[154]	_	_
16-18	2806-2817	performance	abstract[150]|abstract[154]	new[150]|new[154]	_	_
16-19	2818-2819	,	abstract[150]	new[150]	_	_
16-20	2820-2826	visual	abstract[150]|abstract[155]	new[150]|new[155]	_	_
16-21	2827-2839	difficulties	abstract[150]|abstract[155]	new[150]|new[155]	_	_
16-22	2840-2841	,	abstract[150]	new[150]	_	_
16-23	2842-2854	palpitations	abstract[150]|abstract	new[150]|new	_	_
16-24	2855-2856	,	abstract[150]	new[150]	_	_
16-25	2857-2863	nausea	abstract[150]	new[150]	_	_
16-26	2864-2865	,	abstract[150]	new[150]	_	_
16-27	2866-2869	and	abstract[150]	new[150]	_	_
16-28	2870-2878	vomiting	abstract[150]|event	new[150]|new	_	_
16-29	2879-2880	.	_	_	_	_

#Text=Effects in fetus depend on the pregnancy stage in which the poisoning occurs .
17-1	2881-2888	Effects	abstract[158]	new[158]	coref	18-9[165_158]
17-2	2889-2891	in	abstract[158]	new[158]	_	_
17-3	2892-2897	fetus	abstract[158]|event	new[158]|new	coref	19-23[170_0]
17-4	2898-2904	depend	_	_	_	_
17-5	2905-2907	on	_	_	_	_
17-6	2908-2911	the	abstract[161]	new[161]	coref	18-2[163_161]
17-7	2912-2921	pregnancy	abstract|abstract[161]	new|new[161]	coref	19-3
17-8	2922-2927	stage	abstract[161]	new[161]	_	_
17-9	2928-2930	in	_	_	_	_
17-10	2931-2936	which	_	_	_	_
17-11	2937-2940	the	abstract[162]	giv[162]	ana	18-6[0_162]
17-12	2941-2950	poisoning	abstract[162]	giv[162]	_	_
17-13	2951-2957	occurs	_	_	_	_
17-14	2958-2959	.	_	_	_	_

#Text=During the embryonic stage , it can cause skeletal and neurological effects .
18-1	2960-2966	During	_	_	_	_
18-2	2967-2970	the	abstract[163]	giv[163]	_	_
18-3	2971-2980	embryonic	abstract[163]	giv[163]	_	_
18-4	2981-2986	stage	abstract[163]	giv[163]	_	_
18-5	2987-2988	,	_	_	_	_
18-6	2989-2991	it	abstract	giv	ana	19-5
18-7	2992-2995	can	_	_	_	_
18-8	2996-3001	cause	_	_	_	_
18-9	3002-3010	skeletal	abstract[165]	giv[165]	_	_
18-10	3011-3014	and	abstract[165]	giv[165]	_	_
18-11	3015-3027	neurological	abstract[165]	giv[165]	_	_
18-12	3028-3035	effects	abstract[165]	giv[165]	_	_
18-13	3036-3037	.	_	_	_	_

#Text=Later in pregnancy , it is responsible for anoxic encephalopathy , which occurs when there is not enough O delivered to the fetus ’ brain .
19-1	3038-3043	Later	_	_	_	_
19-2	3044-3046	in	_	_	_	_
19-3	3047-3056	pregnancy	event	giv	_	_
19-4	3057-3058	,	_	_	_	_
19-5	3059-3061	it	abstract	giv	_	_
19-6	3062-3064	is	_	_	_	_
19-7	3065-3076	responsible	_	_	_	_
19-8	3077-3080	for	_	_	_	_
19-9	3081-3087	anoxic	abstract[168]	new[168]	_	_
19-10	3088-3102	encephalopathy	abstract[168]	new[168]	_	_
19-11	3103-3104	,	_	_	_	_
19-12	3105-3110	which	_	_	_	_
19-13	3111-3117	occurs	_	_	_	_
19-14	3118-3122	when	_	_	_	_
19-15	3123-3128	there	_	_	_	_
19-16	3129-3131	is	_	_	_	_
19-17	3132-3135	not	_	_	_	_
19-18	3136-3142	enough	_	_	_	_
19-19	3143-3144	O	substance	giv	coref	21-3
19-20	3145-3154	delivered	_	_	_	_
19-21	3155-3157	to	_	_	_	_
19-22	3158-3161	the	object[171]	new[171]	_	_
19-23	3162-3167	fetus	event[170]|object[171]	giv[170]|new[171]	coref	26-25[0_170]
19-24	3168-3169	’	event[170]|object[171]	giv[170]|new[171]	_	_
19-25	3170-3175	brain	object[171]	new[171]	_	_
19-26	3176-3177	.	_	_	_	_

#Text=During gestation , oxygen and nutrients are provided to embryo through the placenta , which uses several transport mechanisms to accomplish this task : simple or facilitated diffusion , active transport , pinocytosis and phagocytosis .
20-1	3178-3184	During	_	_	_	_
20-2	3185-3194	gestation	event	new	_	_
20-3	3195-3196	,	_	_	_	_
20-4	3197-3203	oxygen	substance	giv	_	_
20-5	3204-3207	and	_	_	_	_
20-6	3208-3217	nutrients	substance	new	_	_
20-7	3218-3221	are	_	_	_	_
20-8	3222-3230	provided	_	_	_	_
20-9	3231-3233	to	_	_	_	_
20-10	3234-3240	embryo	animal	new	_	_
20-11	3241-3248	through	_	_	_	_
20-12	3249-3252	the	place[176]	new[176]	_	_
20-13	3253-3261	placenta	place[176]	new[176]	_	_
20-14	3262-3263	,	_	_	_	_
20-15	3264-3269	which	_	_	_	_
20-16	3270-3274	uses	_	_	_	_
20-17	3275-3282	several	abstract[178]	new[178]	_	_
20-18	3283-3292	transport	abstract|abstract[178]	new|new[178]	coref	21-1[181_0]
20-19	3293-3303	mechanisms	abstract[178]	new[178]	_	_
20-20	3304-3306	to	_	_	_	_
20-21	3307-3317	accomplish	_	_	_	_
20-22	3318-3322	this	abstract[179]	new[179]	appos	20-25[180_179]
20-23	3323-3327	task	abstract[179]	new[179]	_	_
20-24	3328-3329	:	_	_	_	_
20-25	3330-3336	simple	abstract[180]	giv[180]	coref	21-9[185_180]
20-26	3337-3339	or	abstract[180]	giv[180]	_	_
20-27	3340-3351	facilitated	abstract[180]	giv[180]	_	_
20-28	3352-3361	diffusion	abstract[180]	giv[180]	_	_
20-29	3362-3363	,	abstract[180]	giv[180]	_	_
20-30	3364-3370	active	abstract[180]	giv[180]	_	_
20-31	3371-3380	transport	abstract[180]	giv[180]	_	_
20-32	3381-3382	,	abstract[180]	giv[180]	_	_
20-33	3383-3394	pinocytosis	abstract[180]	giv[180]	_	_
20-34	3395-3398	and	abstract[180]	giv[180]	_	_
20-35	3399-3411	phagocytosis	abstract[180]	giv[180]	_	_
20-36	3412-3413	.	_	_	_	_

#Text=Transport of O and CO occurs mainly by simple diffusion .
21-1	3414-3423	Transport	abstract[181]	giv[181]	coref	22-7[190_181]
21-2	3424-3426	of	abstract[181]	giv[181]	_	_
21-3	3427-3428	O	abstract[181]|person|substance[183]	giv[181]|giv|giv[183]	coref|coref	22-3|22-3
21-4	3429-3432	and	abstract[181]|substance[183]	giv[181]|giv[183]	_	_
21-5	3433-3435	CO	abstract[181]|substance[183]|substance	giv[181]|giv[183]|giv	coref	22-5
21-6	3436-3442	occurs	_	_	_	_
21-7	3443-3449	mainly	_	_	_	_
21-8	3450-3452	by	_	_	_	_
21-9	3453-3459	simple	abstract[185]	giv[185]	coref	22-17[191_185]
21-10	3460-3469	diffusion	abstract[185]	giv[185]	_	_
21-11	3470-3471	.	_	_	_	_

#Text=Herein , O , CO and CO transport are modeled to occur as a result of simple diffusion of the number of gases dissolved in maternal blood .
22-1	3472-3478	Herein	place	new	_	_
22-2	3479-3480	,	_	_	_	_
22-3	3481-3482	O	person	giv	coref	24-24
22-4	3483-3484	,	_	_	_	_
22-5	3485-3487	CO	substance	giv	coref	22-7
22-6	3488-3491	and	_	_	_	_
22-7	3492-3494	CO	substance|abstract[190]	giv|giv[190]	coref|coref	23-9[196_0]|23-9[196_0]
22-8	3495-3504	transport	abstract[190]	giv[190]	_	_
22-9	3505-3508	are	_	_	_	_
22-10	3509-3516	modeled	_	_	_	_
22-11	3517-3519	to	_	_	_	_
22-12	3520-3525	occur	_	_	_	_
22-13	3526-3528	as	_	_	_	_
22-14	3529-3530	a	_	_	_	_
22-15	3531-3537	result	_	_	_	_
22-16	3538-3540	of	_	_	_	_
22-17	3541-3547	simple	abstract[191]	giv[191]	coref	23-18[198_191]
22-18	3548-3557	diffusion	abstract[191]	giv[191]	_	_
22-19	3558-3560	of	abstract[191]	giv[191]	_	_
22-20	3561-3564	the	abstract[191]|quantity[192]	giv[191]|new[192]	_	_
22-21	3565-3571	number	abstract[191]|quantity[192]	giv[191]|new[192]	_	_
22-22	3572-3574	of	abstract[191]|quantity[192]	giv[191]|new[192]	_	_
22-23	3575-3580	gases	abstract[191]|quantity[192]|substance	giv[191]|new[192]|giv	_	_
22-24	3581-3590	dissolved	_	_	_	_
22-25	3591-3593	in	_	_	_	_
22-26	3594-3602	maternal	substance[194]	giv[194]	_	_
22-27	3603-3608	blood	substance[194]	giv[194]	_	_
22-28	3609-3610	.	_	_	_	_

#Text=However , some authors suggest that , for carbon monoxide , this mechanism could happen due to facilitated diffusion .
23-1	3611-3618	However	_	_	_	_
23-2	3619-3620	,	_	_	_	_
23-3	3621-3625	some	person[195]	new[195]	_	_
23-4	3626-3633	authors	person[195]	new[195]	_	_
23-5	3634-3641	suggest	_	_	_	_
23-6	3642-3646	that	_	_	_	_
23-7	3647-3648	,	_	_	_	_
23-8	3649-3652	for	_	_	_	_
23-9	3653-3659	carbon	substance[196]	giv[196]	coref	24-26[0_196]
23-10	3660-3668	monoxide	substance[196]	giv[196]	_	_
23-11	3669-3670	,	_	_	_	_
23-12	3671-3675	this	abstract[197]	new[197]	_	_
23-13	3676-3685	mechanism	abstract[197]	new[197]	_	_
23-14	3686-3691	could	_	_	_	_
23-15	3692-3698	happen	_	_	_	_
23-16	3699-3702	due	_	_	_	_
23-17	3703-3705	to	_	_	_	_
23-18	3706-3717	facilitated	abstract[198]	giv[198]	_	_
23-19	3718-3727	diffusion	abstract[198]	giv[198]	_	_
23-20	3728-3729	.	_	_	_	_

#Text=Therefore , this work aims at modeling and expanding the phenomenological behavior of a healthy male human lung subjected to the inhalation of O , CO , and CO , first proposed by Albuquerque Neto et al. .
24-1	3730-3739	Therefore	_	_	_	_
24-2	3740-3741	,	_	_	_	_
24-3	3742-3746	this	abstract[199]	new[199]	_	_
24-4	3747-3751	work	abstract[199]	new[199]	_	_
24-5	3752-3756	aims	_	_	_	_
24-6	3757-3759	at	_	_	_	_
24-7	3760-3768	modeling	_	_	_	_
24-8	3769-3772	and	_	_	_	_
24-9	3773-3782	expanding	_	_	_	_
24-10	3783-3786	the	abstract[200]	giv[200]	_	_
24-11	3787-3803	phenomenological	abstract[200]	giv[200]	_	_
24-12	3804-3812	behavior	abstract[200]	giv[200]	_	_
24-13	3813-3815	of	abstract[200]	giv[200]	_	_
24-14	3816-3817	a	abstract[200]|object[201]	giv[200]|new[201]	_	_
24-15	3818-3825	healthy	abstract[200]|object[201]	giv[200]|new[201]	_	_
24-16	3826-3830	male	abstract[200]|object[201]	giv[200]|new[201]	_	_
24-17	3831-3836	human	abstract[200]|object[201]	giv[200]|new[201]	_	_
24-18	3837-3841	lung	abstract[200]|object[201]	giv[200]|new[201]	_	_
24-19	3842-3851	subjected	_	_	_	_
24-20	3852-3854	to	_	_	_	_
24-21	3855-3858	the	abstract[202]	new[202]	_	_
24-22	3859-3869	inhalation	abstract[202]	new[202]	_	_
24-23	3870-3872	of	abstract[202]	new[202]	_	_
24-24	3873-3874	O	abstract[202]|substance	new[202]|giv	_	_
24-25	3875-3876	,	abstract[202]	new[202]	_	_
24-26	3877-3879	CO	abstract[202]|substance	new[202]|giv	coref	24-29
24-27	3880-3881	,	abstract[202]	new[202]	_	_
24-28	3882-3885	and	abstract[202]	new[202]	_	_
24-29	3886-3888	CO	abstract[202]|substance	new[202]|giv	_	_
24-30	3889-3890	,	_	_	_	_
24-31	3891-3896	first	_	_	_	_
24-32	3897-3905	proposed	_	_	_	_
24-33	3906-3908	by	_	_	_	_
24-34	3909-3920	Albuquerque	person[206]	new[206]	_	_
24-35	3921-3925	Neto	person[206]	new[206]	_	_
24-36	3926-3928	et	_	_	_	_
24-37	3929-3932	al.	_	_	_	_
24-38	3933-3934	.	_	_	_	_

#Text=Moreover , based on the exergy method proposed by Henriques et al. and Cenzi et al. , the objective is to expand the phenomenological and exergy model to a pregnant woman subjected to conditions usually found in urban ecosystems and during stress periods such as passive smoking or prolonged exposure to a tunnel environment .
25-1	3935-3943	Moreover	_	_	_	_
25-2	3944-3945	,	_	_	_	_
25-3	3946-3951	based	_	_	_	_
25-4	3952-3954	on	_	_	_	_
25-5	3955-3958	the	abstract[208]	new[208]	_	_
25-6	3959-3965	exergy	abstract|abstract[208]	giv|new[208]	_	_
25-7	3966-3972	method	abstract[208]	new[208]	_	_
25-8	3973-3981	proposed	_	_	_	_
25-9	3982-3984	by	_	_	_	_
25-10	3985-3994	Henriques	person	new	_	_
25-11	3995-3997	et	_	_	_	_
25-12	3998-4001	al.	_	_	_	_
25-13	4002-4005	and	_	_	_	_
25-14	4006-4011	Cenzi	person	new	_	_
25-15	4012-4014	et	_	_	_	_
25-16	4015-4018	al.	_	_	_	_
25-17	4019-4020	,	_	_	_	_
25-18	4021-4024	the	event[211]	new[211]	_	_
25-19	4025-4034	objective	event[211]	new[211]	_	_
25-20	4035-4037	is	_	_	_	_
25-21	4038-4040	to	_	_	_	_
25-22	4041-4047	expand	_	_	_	_
25-23	4048-4051	the	abstract[212]	new[212]	_	_
25-24	4052-4068	phenomenological	abstract[212]	new[212]	_	_
25-25	4069-4072	and	abstract[212]	new[212]	_	_
25-26	4073-4079	exergy	abstract[212]	new[212]	_	_
25-27	4080-4085	model	abstract[212]	new[212]	_	_
25-28	4086-4088	to	_	_	_	_
25-29	4089-4090	a	person[213]	new[213]	coref	26-14[226_213]
25-30	4091-4099	pregnant	person[213]	new[213]	_	_
25-31	4100-4105	woman	person[213]	new[213]	_	_
25-32	4106-4115	subjected	_	_	_	_
25-33	4116-4118	to	_	_	_	_
25-34	4119-4129	conditions	abstract	giv	coref	26-11[225_0]
25-35	4130-4137	usually	_	_	_	_
25-36	4138-4143	found	_	_	_	_
25-37	4144-4146	in	_	_	_	_
25-38	4147-4152	urban	place[215]	new[215]	_	_
25-39	4153-4163	ecosystems	place[215]	new[215]	_	_
25-40	4164-4167	and	_	_	_	_
25-41	4168-4174	during	_	_	_	_
25-42	4175-4181	stress	abstract|time[217]	new|new[217]	_	_
25-43	4182-4189	periods	time[217]	new[217]	_	_
25-44	4190-4194	such	time[217]	new[217]	_	_
25-45	4195-4197	as	time[217]	new[217]	_	_
25-46	4198-4205	passive	time[217]|event[218]	new[217]|new[218]	_	_
25-47	4206-4213	smoking	time[217]|event[218]	new[217]|new[218]	_	_
25-48	4214-4216	or	time[217]	new[217]	_	_
25-49	4217-4226	prolonged	time[217]|abstract[219]	new[217]|new[219]	_	_
25-50	4227-4235	exposure	time[217]|abstract[219]	new[217]|new[219]	_	_
25-51	4236-4238	to	time[217]|abstract[219]	new[217]|new[219]	_	_
25-52	4239-4240	a	time[217]|abstract[219]|place[221]	new[217]|new[219]|giv[221]	_	_
25-53	4241-4247	tunnel	time[217]|abstract[219]|object|place[221]	new[217]|new[219]|giv|giv[221]	_	_
25-54	4248-4259	environment	time[217]|abstract[219]|place[221]	new[217]|new[219]|giv[221]	_	_
25-55	4260-4261	.	_	_	_	_

#Text=The distinguishing feature of this article is the application of these conditions to a pregnant woman , with a phenomenological of the mother and fetus ( proposed in the present article ) .
26-1	4262-4265	The	abstract[222]	new[222]	coref	26-8[224_222]
26-2	4266-4280	distinguishing	abstract[222]	new[222]	_	_
26-3	4281-4288	feature	abstract[222]	new[222]	_	_
26-4	4289-4291	of	abstract[222]	new[222]	_	_
26-5	4292-4296	this	abstract[222]|object[223]	new[222]|new[223]	coref	26-29[229_223]
26-6	4297-4304	article	abstract[222]|object[223]	new[222]|new[223]	_	_
26-7	4305-4307	is	_	_	_	_
26-8	4308-4311	the	abstract[224]	giv[224]	_	_
26-9	4312-4323	application	abstract[224]	giv[224]	_	_
26-10	4324-4326	of	abstract[224]	giv[224]	_	_
26-11	4327-4332	these	abstract[224]|abstract[225]	giv[224]|giv[225]	_	_
26-12	4333-4343	conditions	abstract[224]|abstract[225]	giv[224]|giv[225]	_	_
26-13	4344-4346	to	abstract[224]|abstract[225]	giv[224]|giv[225]	_	_
26-14	4347-4348	a	abstract[224]|abstract[225]|person[226]	giv[224]|giv[225]|giv[226]	coref	26-22[227_226]
26-15	4349-4357	pregnant	abstract[224]|abstract[225]|person[226]	giv[224]|giv[225]|giv[226]	_	_
26-16	4358-4363	woman	abstract[224]|abstract[225]|person[226]	giv[224]|giv[225]|giv[226]	_	_
26-17	4364-4365	,	abstract[224]	giv[224]	_	_
26-18	4366-4370	with	abstract[224]	giv[224]	_	_
26-19	4371-4372	a	abstract[224]	giv[224]	_	_
26-20	4373-4389	phenomenological	abstract[224]	giv[224]	_	_
26-21	4390-4392	of	_	_	_	_
26-22	4393-4396	the	person[227]	giv[227]	_	_
26-23	4397-4403	mother	person[227]	giv[227]	_	_
26-24	4404-4407	and	person[227]	giv[227]	_	_
26-25	4408-4413	fetus	person[227]|event	giv[227]|giv	_	_
26-26	4414-4415	(	_	_	_	_
26-27	4416-4424	proposed	_	_	_	_
26-28	4425-4427	in	_	_	_	_
26-29	4428-4431	the	object[229]	giv[229]	_	_
26-30	4432-4439	present	object[229]	giv[229]	_	_
26-31	4440-4447	article	object[229]	giv[229]	_	_
26-32	4448-4449	)	_	_	_	_
26-33	4450-4451	.	_	_	_	_
